You have read all your free articles, to continue reading subscribe to read the rest of this content.
AstraZeneca's EVP of Oncology R&D, José Baselga, shares his top five takeaways from the AACR COVID-19 and Cancer virtual meeting. The American Association for Cancer Research (AACR) organized a COVID-19 and Cancer virtual meeting, bringing together voices from across the healthcare continuumAlready a subscriber Login You have read all your…
Novo Nordisk announced results from a phase 2 clinical trial of investigational insulin icodec, a once-weekly basal insulin analogue. In the trial, adults with type 2 diabetes randomised to once-weekly insulin icodec achieved similar blood sugar control and a similar safety profile compared with Already a subscriber Login You have…
Immunicum has announced the completion of the Phase Ib portion of the ILIAD study evaluating the company’s off-the-shelf, cell-based immune primer ilixadencel in combination with anti-PD1 checkpoint inhibitor (CPI) pembrolizumab (Keytruda) in different cancer indications. All subjects in the PhAlready a subscriber Login You have read all your free articles,…
Following the recent update on clinicaltrials.gov, AstraZeneca confirms that the US FDA has placed a partial clinical hold on the enrolment of new patients with head and neck squamous cell carcinoma (HNSCC) in clinical trials of durvalumab as monotherapy and in combination with tremelimumab or otherAlready a subscriber Login You…
